Loring Wolcott & Coolidge Fiduciary Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-26	Closed	-$2K	–	711
2019 Q2	$2K	Buy	+26	New	+$2K	﹤0.01%	663
2017 Q4	–	Sell	-13	Closed	-$1K	–	817
2017 Q3	$1K	Buy	+13	New	+$1K	﹤0.01%	720